Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

Current status:

Cancelled Post Market

Current status date:

2015-08-05

Original market date: See footnote 1

1996-12-31

Product name:

2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE

DIN:

02143267 Electronic product monograph is not available

Company:

BAXTER CORPORATION CLINTEC NUTRITION DIVISION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

20

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:20.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BA10 COMBINATIONS

Active ingredient group (AIG) number:See footnote5

2050851008

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
DEXTROSE 10 G / 100 ML
Glycine 260 MG / 100 ML
Histidine 120 MG / 100 ML
L-ALANINE 520 MG / 100 ML
L-arginine 290 MG / 100 ML
L-isoleucine 150 MG / 100 ML
L-leucine 182.5 MG / 100 ML
L-lysine (Chlorhydrate de L-lysine) 145 MG / 100 ML
L-phénylalanine 140 MG / 100 ML
L-proline 170 MG / 100 ML
L-thréonine 105 MG / 100 ML
L-tyrosine 10 MG / 100 ML
L-valine 145 MG / 100 ML
Chlorure de magnésium 25.5 MG / 100 ML
Méhionine 100 MG / 100 ML
Phosphate de potassium dibasique 130.5 MG / 100 ML
Sérine 125 MG / 100 ML
Acétate de sodium 170 MG / 100 ML
Chlorure de sodium 29.3 MG / 100 ML
Tryptophane 45 MG / 100 ML
Version 4.0.3

"Page details"

Date modified: